Comparison 6.
Constant CGM versus intermittent CGM
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 Caesarean section | 1 | 25 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.77 [0.33, 1.79] |
| 2 Weight gain during pregnancy | 1 | 25 | Mean Difference (IV, Fixed, 95% CI) | 0.5 [‐1.82, 2.82] |
| 3 Insulin dosage, 3rd trimester (IU/kg/day) | 1 | 25 | Mean Difference (IV, Fixed, 95% CI) | ‐0.03 [‐1.30, 1.24] |
| 4 Glycaemic control ‐ Maternal blood glucose (1st trimester) | 1 | 25 | Mean Difference (IV, Fixed, 95% CI) | ‐0.5 [‐2.70, 1.70] |
| 5 Glycaemic control ‐ Maternal blood glucose (3rd trimester) | 1 | 25 | Mean Difference (IV, Fixed, 95% CI) | ‐0.14 [‐2.00, 1.72] |
| 6 Glycaemic control ‐ Maternal HbA1c (1st trimester) | 1 | 25 | Mean Difference (IV, Fixed, 95% CI) | ‐0.30 [‐1.13, 0.53] |
| 7 Glycaemic control ‐ Maternal HbA1c (3rd trimester) | 1 | 25 | Mean Difference (IV, Fixed, 95% CI) | ‐0.09 [‐0.69, 0.51] |
| 8 Maternal hypoglycemia | 1 | 25 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.54 [0.06, 5.24] |
| 9 Diabetic ketoacidosis (not pre‐specified) | 1 | 25 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.36 [0.02, 8.05] |
| 10 Preterm birth < 37 weeks | 1 | 25 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.08 [0.08, 15.46] |
| 11 Macrosomia | 1 | 25 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.08 [0.08, 15.46] |
| 12 Neonatal hypoglycaemia | 1 | 25 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.0 [0.0, 0.0] |